FWSM
TMBR

First Wilshire Securities Management’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

First Wilshire Securities Management’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4
Closed -$17K – 126
2017
Q3 		$17K Hold
4
– – ﹤0.01% 121
2017
Q2 		$28K Buy
4
+2
+100% +$17.4K 0.01% 121
2017
Q1 		$14K Hold
2
– – ﹤0.01% 127
2016
Q4 		$10K Hold
2
– – ﹤0.01% 125
2016
Q3 		$16K Buy
+2
New +$21.1K ﹤0.01% 118

Other funds holding TMBR

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

First Wilshire Securities Management's TMBR Position: Q4 2017 in Review

First Wilshire Securities Management sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2017, closing a stake of 4 shares — an estimated $17K sold.

First Wilshire Securities Management first reported a position in TMBR in Q3 2016 and held it in 5 quarters. The position peaked at $28K in Q2 2017. 15 funds tracked by Wall St. Rank hold TMBR as of Q4 2017.

  • First Wilshire Securities Management reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • First Wilshire Securities Management sold 4 Timber Pharmaceuticals, Inc. shares in Q4 2017, an estimated $17K.
  • First Wilshire Securities Management first reported a position in Timber Pharmaceuticals, Inc. in Q3 2016 and held it in 5 quarters.
  • First Wilshire Securities Management's Timber Pharmaceuticals, Inc. position peaked at $28K in Q2 2017.
  • 15 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2017.

Based on First Wilshire Securities Management's 13F filing for Q4 2017, filed 15 Feb 2018.